Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention - AHA | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
AHA
2021
·
USA
·
Cardiology
Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention
Document
Analyser ce document
